• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Telmisartan Market Insights, Forecast to 2026

report cover
  • 3 September 2020
  • Healthcare
  • 148 Pages
  • Report Code: 24LS-21502
  • Formate :   
Download FREE Report Sample Download PDF File

United States Telmisartan -MARKET ADVISORY SERVICES

Telmisartan market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Telmisartan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Telmisartan market is segmented into
Injection
Freeze-Dried Powder

Segment by Application, the Telmisartan market is segmented into
Hospital Use
Clinic Use
Others

Regional and Country-level Analysis
The Telmisartan market is analysed and market size information is provided by regions (countries).
The key regions covered in the Telmisartan market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Telmisartan Market Share Analysis
Telmisartan market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Telmisartan business, the date to enter into the Telmisartan market, Telmisartan product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy's Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
1 Study Coverage
1.1 Telmisartan Product Introduction
1.2 Market Segments
1.3 Key Telmisartan Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Telmisartan Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-Dried Powder
1.5 Market by Application
1.5.1 Global Telmisartan Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Telmisartan Market Size, Estimates and Forecasts
2.1.1 Global Telmisartan Revenue 2015-2026
2.1.2 Global Telmisartan Sales 2015-2026
2.2 Global Telmisartan, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Telmisartan Historical Market Size by Region (2015-2020)
2.3.1 Global Telmisartan Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Telmisartan Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Telmisartan Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Telmisartan Sales Forecast by Region (2021-2026)
2.4.2 Global Telmisartan Revenue Forecast by Region (2021-2026)

3 Global Telmisartan Competitor Landscape by Players
3.1 Global Top Telmisartan Sales by Manufacturers
3.1.1 Global Telmisartan Sales by Manufacturers (2015-2020)
3.1.2 Global Telmisartan Sales Market Share by Manufacturers (2015-2020)
3.2 Global Telmisartan Manufacturers by Revenue
3.2.1 Global Telmisartan Revenue by Manufacturers (2015-2020)
3.2.2 Global Telmisartan Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Telmisartan Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Telmisartan Revenue in 2019
3.2.5 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Telmisartan Price by Manufacturers
3.4 Global Telmisartan Manufacturing Base Distribution, Product Types
3.4.1 Telmisartan Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Telmisartan Product Type
3.4.3 Date of International Manufacturers Enter into Telmisartan Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Telmisartan Market Size by Type (2015-2020)
4.1.1 Global Telmisartan Sales by Type (2015-2020)
4.1.2 Global Telmisartan Revenue by Type (2015-2020)
4.1.3 Telmisartan Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Telmisartan Market Size Forecast by Type (2021-2026)
4.2.1 Global Telmisartan Sales Forecast by Type (2021-2026)
4.2.2 Global Telmisartan Revenue Forecast by Type (2021-2026)
4.2.3 Telmisartan Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Telmisartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Telmisartan Market Size by Application (2015-2020)
5.1.1 Global Telmisartan Sales by Application (2015-2020)
5.1.2 Global Telmisartan Revenue by Application (2015-2020)
5.1.3 Telmisartan Price by Application (2015-2020)
5.2 Telmisartan Market Size Forecast by Application (2021-2026)
5.2.1 Global Telmisartan Sales Forecast by Application (2021-2026)
5.2.2 Global Telmisartan Revenue Forecast by Application (2021-2026)
5.2.3 Global Telmisartan Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Telmisartan Market Size YoY Growth 2015-2026
6.1.1 United States Telmisartan Sales YoY Growth 2015-2026
6.1.2 United States Telmisartan Revenue YoY Growth 2015-2026
6.1.3 United States Telmisartan Market Share in Global Market 2015-2026
6.2 United States Telmisartan Market Size by Players (International and Local Players)
6.2.1 United States Top Telmisartan Players by Sales (2015-2020)
6.2.2 United States Top Telmisartan Players by Revenue (2015-2020)
6.3 United States Telmisartan Historic Market Review by Type (2015-2020)
6.3.1 United States Telmisartan Sales Market Share by Type (2015-2020)
6.3.2 United States Telmisartan Revenue Market Share by Type (2015-2020)
6.3.3 United States Telmisartan Price by Type (2015-2020)
6.4 United States Telmisartan Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Telmisartan Sales Forecast by Type (2021-2026)
6.4.2 United States Telmisartan Revenue Forecast by Type (2021-2026)
6.4.3 United States Telmisartan Price Forecast by Type (2021-2026)
6.5 United States Telmisartan Historic Market Review by Application (2015-2020)
6.5.1 United States Telmisartan Sales Market Share by Application (2015-2020)
6.5.2 United States Telmisartan Revenue Market Share by Application (2015-2020)
6.5.3 United States Telmisartan Price by Application (2015-2020)
6.6 United States Telmisartan Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Telmisartan Sales Forecast by Application (2021-2026)
6.6.2 United States Telmisartan Revenue Forecast by Application (2021-2026)
6.6.3 United States Telmisartan Price Forecast by Application (2021-2026)

7 North America
7.1 North America Telmisartan Market Size YoY Growth 2015-2026
7.2 North America Telmisartan Market Facts & Figures by Country
7.2.1 North America Telmisartan Sales by Country (2015-2020)
7.2.2 North America Telmisartan Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Telmisartan Market Size YoY Growth 2015-2026
8.2 Europe Telmisartan Market Facts & Figures by Country
8.2.1 Europe Telmisartan Sales by Country
8.2.2 Europe Telmisartan Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Telmisartan Market Size YoY Growth 2015-2026
9.2 Asia Pacific Telmisartan Market Facts & Figures by Country
9.2.1 Asia Pacific Telmisartan Sales by Region (2015-2020)
9.2.2 Asia Pacific Telmisartan Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Telmisartan Market Size YoY Growth 2015-2026
10.2 Latin America Telmisartan Market Facts & Figures by Country
10.2.1 Latin America Telmisartan Sales by Country
10.2.2 Latin America Telmisartan Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Telmisartan Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Telmisartan Market Facts & Figures by Country
11.2.1 Middle East and Africa Telmisartan Sales by Country
11.2.2 Middle East and Africa Telmisartan Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Telmisartan Products Offered
12.1.5 Pfizer Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Description and Business Overview
12.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Telmisartan Products Offered
12.2.5 Teva Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Telmisartan Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Telmisartan Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Description and Business Overview
12.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Telmisartan Products Offered
12.5.5 Mylan Recent Development
12.6 Reddy's Laboratories (UK)
12.6.1 Reddy's Laboratories (UK) Corporation Information
12.6.2 Reddy's Laboratories (UK) Description and Business Overview
12.6.3 Reddy's Laboratories (UK) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Reddy's Laboratories (UK) Telmisartan Products Offered
12.6.5 Reddy's Laboratories (UK) Recent Development
12.7 Hema Pharmaceuticals Pvt
12.7.1 Hema Pharmaceuticals Pvt Corporation Information
12.7.2 Hema Pharmaceuticals Pvt Description and Business Overview
12.7.3 Hema Pharmaceuticals Pvt Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
12.7.5 Hema Pharmaceuticals Pvt Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Description and Business Overview
12.8.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer Telmisartan Products Offered
12.8.5 Bayer Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Description and Business Overview
12.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GSK Telmisartan Products Offered
12.9.5 GSK Recent Development
12.10 Astellas Pharma Inc
12.10.1 Astellas Pharma Inc Corporation Information
12.10.2 Astellas Pharma Inc Description and Business Overview
12.10.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Astellas Pharma Inc Telmisartan Products Offered
12.10.5 Astellas Pharma Inc Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Telmisartan Products Offered
12.11.5 Pfizer Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Description and Business Overview
12.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott Products Offered
12.12.5 Abbott Recent Development
12.13 Takeda
12.13.1 Takeda Corporation Information
12.13.2 Takeda Description and Business Overview
12.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Takeda Products Offered
12.13.5 Takeda Recent Development
12.14 Beijing Wansheng Pharmaceutical
12.14.1 Beijing Wansheng Pharmaceutical Corporation Information
12.14.2 Beijing Wansheng Pharmaceutical Description and Business Overview
12.14.3 Beijing Wansheng Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Beijing Wansheng Pharmaceutical Products Offered
12.14.5 Beijing Wansheng Pharmaceutical Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Telmisartan Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Telmisartan Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Telmisartan Market Segments

Table 2. Ranking of Global Top Telmisartan Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Telmisartan Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)

Table 4. Major Manufacturers of Injection

Table 5. Major Manufacturers of Freeze-Dried Powder

Table 6. Global Telmisartan Market Size Growth Rate by Application 2020-2026 (MT)

Table 7. Global Telmisartan Market Size by Region (MT) & (US$ Million): 2020 VS 2026

Table 8. Global Telmisartan Sales by Regions 2015-2020 (MT)

Table 9. Global Telmisartan Sales Market Share by Regions (2015-2020)

Table 10. Global Telmisartan Revenue by Regions 2015-2020 (US$ Million)

Table 11. Global Telmisartan Sales Forecast by Region (2021-2026) (MT)

Table 12. Global Telmisartan Sales by Manufacturers (2015-2020) (MT)

Table 13. Global Telmisartan Sales Share by Manufacturers (2015-2020)

Table 14. Global Telmisartan Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)

Table 16. Telmisartan Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Telmisartan Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Telmisartan Price (2015-2020) (USD/Kg)

Table 19. Telmisartan Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Telmisartan Product Type

Table 21. Date of International Manufacturers Enter into Telmisartan Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Telmisartan Sales by Type (2015-2020) (MT)

Table 24. Global Telmisartan Sales Share by Type (2015-2020)

Table 25. Global Telmisartan Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Telmisartan Revenue Share by Type (2015-2020)

Table 27. Telmisartan Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)

Table 28. Global Telmisartan Sales Share by Type (2021-2026)

Table 29. Global Telmisartan Sales by Application (2015-2020) (MT)

Table 30. Global Telmisartan Sales Share by Application (2015-2020)

Table 31. Global Telmisartan Sales Share by Application (2021-2026)

Table 32. Global Telmisartan Sales Market Share Forecast by Application (2021-2026)

Table 33. Global Telmisartan Revenue by Application (2015-2020) (US$ Million)

Table 34. Global Telmisartan Revenue Market Share Forecast by Application (2021-2026)

Table 35. United States Telmisartan Sales (MT) of Key Companies (2015-2020)

Table 36. United States Telmisartan Sales Share by Company (2015-2020)

Table 37. United States Telmisartan Revenue (US$ Million) by Company (2015-2020)

Table 38. United States Telmisartan Sales (MT) by Type (2015-2020)

Table 39. United States Telmisartan Sales Share by Type (2015-2020)

Table 40. United States Telmisartan Revenue (US$ Million) Market Share by Type (2015-2020)

Table 41. United States Telmisartan Price (MT) by Type (2015-2020)

Table 42. United States Telmisartan Sales (MT) by Type (2021-2026)

Table 43. United States Telmisartan Sales Share by Type (2021-2026)

Table 44. United States Telmisartan Revenue (US$ Million) Market Share by Type (2021-2026)

Table 45. United States Telmisartan Revenue Share by Type (2021-2026)

Table 46. United States Telmisartan Price (MT) by Type (2021-2026)

Table 47. United States Telmisartan Sales (MT) by Application (2015-2020)

Table 48. United States Telmisartan Sales Share by Application (2015-2020)

Table 49. United States Telmisartan Revenue (US$ Million) Market Share by Application (2015-2020)

Table 50. United States Telmisartan Sales (MT) by Application (2021-2026)

Table 51. United States Telmisartan Sales Share by Application (2021-2026)

Table 52. United States Telmisartan Revenue (US$ Million) Market Share by Application (2021-2026)

Table 53. United States Telmisartan Revenue Share by Application (2021-2026)

Table 54. North America Telmisartan Sales by Country (2015-2020) (MT)

Table 55. North America Telmisartan Sales Market Share by Country (2015-2020)

Table 56. North America Telmisartan Revenue by Country (2015-2020) (US$ Million)

Table 57. North America Telmisartan Revenue Market Share by Country (2015-2020)

Table 58. Europe Telmisartan Sales by Country (2015-2020) (MT)

Table 59. Europe Telmisartan Sales Market Share by Country (2015-2020)

Table 60. Europe Telmisartan Revenue by Country (2015-2020) (US$ Million)

Table 61. Europe Telmisartan Revenue Market Share by Country (2015-2020)

Table 62. Asia Pacific Telmisartan Sales by Region (2015-2020) (MT)

Table 63. Asia Pacific Telmisartan Sales Market Share by Region (2015-2020)

Table 64. Asia Pacific Telmisartan Revenue by Region (2015-2020) (US$ Million)

Table 65. Asia Pacific Telmisartan Revenue Market Share by Region (2015-2020)

Table 66. Latin America Telmisartan Sales by Country (2015-2020) (MT)

Table 67. Latin America Telmisartan Sales Market Share by Country (2015-2020)

Table 68. Latin Americaa Telmisartan Revenue by Country (2015-2020) (US$ Million)

Table 69. Latin America Telmisartan Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Telmisartan Sales by Country (2015-2020) (MT)

Table 71. Middle East and Africa Telmisartan Sales Market Share by Country (2015-2020)

Table 72. Middle East and Africa Telmisartan Revenue by Country (2015-2020) (US$ Million)

Table 73. Middle East and Africa Telmisartan Revenue Market Share by Country (2015-2020)

Table 74. Pfizer Corporation Information

Table 75. Pfizer Description and Business Overview

Table 76. Pfizer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 77. Pfizer Telmisartan Product

Table 78. Pfizer Recent Development

Table 79. Teva Corporation Information

Table 80. Teva Description and Business Overview

Table 81. Teva Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 82. Teva Product

Table 83. Teva Recent Development

Table 84. Boehringer Ingelheim Corporation Information

Table 85. Boehringer Ingelheim Description and Business Overview

Table 86. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 87. Boehringer Ingelheim Product

Table 88. Boehringer Ingelheim Recent Development

Table 89. Novartis Corporation Information

Table 90. Novartis Description and Business Overview

Table 91. Novartis Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 92. Novartis Product

Table 93. Novartis Recent Development

Table 94. Mylan Corporation Information

Table 95. Mylan Description and Business Overview

Table 96. Mylan Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 97. Mylan Product

Table 98. Mylan Recent Development

Table 99. Reddy's Laboratories (UK) Corporation Information

Table 100. Reddy's Laboratories (UK) Description and Business Overview

Table 101. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 102. Reddy's Laboratories (UK) Product

Table 103. Reddy's Laboratories (UK) Recent Development

Table 104. Hema Pharmaceuticals Pvt Corporation Information

Table 105. Hema Pharmaceuticals Pvt Description and Business Overview

Table 106. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 107. Hema Pharmaceuticals Pvt Product

Table 108. Hema Pharmaceuticals Pvt Recent Development

Table 109. Bayer Corporation Information

Table 110. Bayer Description and Business Overview

Table 111. Bayer Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 112. Bayer Product

Table 113. Bayer Recent Development

Table 114. GSK Corporation Information

Table 115. GSK Description and Business Overview

Table 116. GSK Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 117. GSK Product

Table 118. GSK Recent Development

Table 119. Astellas Pharma Inc Corporation Information

Table 120. Astellas Pharma Inc Description and Business Overview

Table 121. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 122. Astellas Pharma Inc Product

Table 123. Astellas Pharma Inc Recent Development

Table 124. Nippon Boehringer Ingelheim Corporation Information

Table 125. Nippon Boehringer Ingelheim Description and Business Overview

Table 126. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 127. Nippon Boehringer Ingelheim Product

Table 128. Nippon Boehringer Ingelheim Recent Development

Table 129. Abbott Corporation Information

Table 130. Abbott Description and Business Overview

Table 131. Abbott Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 132. Abbott Product

Table 133. Abbott Recent Development

Table 134. Takeda Corporation Information

Table 135. Takeda Description and Business Overview

Table 136. Takeda Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 137. Takeda Product

Table 138. Takeda Recent Development

Table 139. Beijing Wansheng Pharmaceutical Corporation Information

Table 140. Beijing Wansheng Pharmaceutical Description and Business Overview

Table 141. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)

Table 142. Beijing Wansheng Pharmaceutical Product

Table 143. Beijing Wansheng Pharmaceutical Recent Development

Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 145. Key Challenges

Table 146. Market Risks

Table 147. Main Points Interviewed from Key Telmisartan Players

Table 148. Telmisartan Customers List

Table 149. Telmisartan Distributors List

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Telmisartan Product Picture

Figure 2. Global Telmisartan Sales Market Share by Type in 2020 & 2026

Figure 3. Injection Product Picture

Figure 4. Freeze-Dried Powder Product Picture

Figure 5. Global Telmisartan Sales Market Share by Application in 2020 & 2026

Figure 6. Hospital Use

Figure 7. Clinic Use

Figure 8. Others

Figure 9. Telmisartan Report Years Considered

Figure 10. Global Telmisartan Market Size 2015-2026 (US$ Million)

Figure 11. Global Telmisartan Sales 2015-2026 (MT)

Figure 12. Global Telmisartan Market Size Market Share by Region: 2020 Versus 2026

Figure 13. Global Telmisartan Sales Market Share by Region (2015-2020)

Figure 14. Global Telmisartan Sales Market Share by Region in 2019

Figure 15. Global Telmisartan Revenue Market Share by Region (2015-2020)

Figure 16. Global Telmisartan Revenue Market Share by Region in 2019

Figure 17. Global Telmisartan Sales Share by Manufacturer in 2019

Figure 18. The Top 10 and 5 Players Market Share by Telmisartan Revenue in 2019

Figure 19. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 20. Global Telmisartan Sales Market Share by Type (2015-2020)

Figure 21. Global Telmisartan Sales Market Share by Type in 2019

Figure 22. Global Telmisartan Revenue Market Share by Type (2015-2020)

Figure 23. Global Telmisartan Revenue Market Share by Type in 2019

Figure 24. Global Telmisartan Market Share by Price Range (2015-2020)

Figure 25. Global Telmisartan Sales Market Share by Application (2015-2020)

Figure 26. Global Telmisartan Sales Market Share by Application in 2019

Figure 27. Global Telmisartan Revenue Market Share by Application (2015-2020)

Figure 28. Global Telmisartan Revenue Market Share by Application in 2019

Figure 29. United States Telmisartan Sales Growth Rate 2015-2026 (MT)

Figure 30. United States Telmisartan Revenue Growth Rate 2015-2026 (US$ Million)

Figure 31. United States Telmisartan Market Share in Global Market 2015-2026

Figure 32. United States 5 and 10 Largest Telmisartan Players Market Share by Revenue in Telmisartan in 2019

Figure 33. United States Telmisartan Revenue Share by Type (2015-2020)

Figure 34. United States Telmisartan Revenue Growth Rate by Type in 2015 & 2019

Figure 35. United States Telmisartan Revenue Share by Application (2015-2020)

Figure 36. United States Telmisartan Revenue Growth Rate by Application in 2015 & 2019

Figure 37. North America Telmisartan Sales Growth Rate 2015-2020 (MT)

Figure 38. North America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)

Figure 39. North America Telmisartan Sales Market Share by Country in 2019

Figure 40. North America Telmisartan Revenue Market Share by Country in 2019

Figure 41. U.S. Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 42. U.S. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 43. Canada Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 44. Canada Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Europe Telmisartan Sales Growth Rate 2015-2020 (MT)

Figure 46. Europe Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)

Figure 47. Europe Telmisartan Sales Market Share by Country in 2019

Figure 48. Europe Telmisartan Revenue Market Share by Country in 2019

Figure 49. Germany Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 50. Germany Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. France Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 52. France Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. U.K. Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 54. U.K. Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Italy Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 56. Italy Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Russia Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 58. Russia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Asia Pacific Telmisartan Sales Growth Rate 2015-2020 (MT)

Figure 60. Asia Pacific Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)

Figure 61. Asia Pacific Telmisartan Sales Market Share by Region in 2019

Figure 62. Asia Pacific Telmisartan Revenue Market Share by Region in 2019

Figure 63. China Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 64. China Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 65. Japan Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 66. Japan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. South Korea Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 68. South Korea Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. India Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 70. India Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. Australia Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 72. Australia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Taiwan Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 74. Taiwan Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Indonesia Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 76. Indonesia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Thailand Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 78. Thailand Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Malaysia Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 80. Malaysia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Philippines Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 82. Philippines Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Vietnam Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 84. Vietnam Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Latin America Telmisartan Sales Growth Rate 2015-2020 (MT)

Figure 86. Latin America Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)

Figure 87. Latin America Telmisartan Sales Market Share by Country in 2019

Figure 88. Latin America Telmisartan Revenue Market Share by Country in 2019

Figure 89. Mexico Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 90. Mexico Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 91. Brazil Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 92. Brazil Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Argentina Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 94. Argentina Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Middle East and Africa Telmisartan Sales Growth Rate 2015-2020 (MT)

Figure 96. Middle East and Africa Telmisartan Revenue Growth Rate 2015-2020 (US$ Million)

Figure 97. Middle East and Africa Telmisartan Sales Market Share by Country in 2019

Figure 98. Middle East and Africa Telmisartan Revenue Market Share by Country in 2019

Figure 99. Turkey Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 100. Turkey Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 101. Saudi Arabia Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 102. Saudi Arabia Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. U.A.E Telmisartan Sales Growth Rate (2015-2020) (MT)

Figure 104. U.A.E Telmisartan Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. Porter's Five Forces Analysis

Figure 106. Telmisartan Value Chain

Figure 107. Channels of Distribution

Figure 108. Distributors Profiles

Figure 109. Bottom-up and Top-down Approaches for This Report

Figure 110. Data Triangulation

Figure 111. Key Executives Interviewed

Pfizer

Teva

Boehringer Ingelheim

Novartis

Mylan

Reddy's Laboratories (UK)

Hema Pharmaceuticals Pvt

Bayer

GSK

Astellas Pharma Inc

Nippon Boehringer Ingelheim

Abbott

Takeda

Beijing Wansheng Pharmaceutical

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3315

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase